Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT06361303 · Happiest Baby, Inc.

The Happiest Baby, Inc. SNOO Postmarket Surveillance Study

What this study is about

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

View original scientific description

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Infant/caregiver dyads meeting the following inclusion criteria will be eligible for study enrollment:
  • Respondent must identify as a primary caregiver of the infant.
  • Purchase or rental of SNOO shipped to a U.S. residence during the defined enrollment period.
  • Caregivers must be English speakers ages 18 or older residing in the United States.
  • Infants must use SNOO during the intended use period (i.e., birth to 6 months).
  • Infants must meet at least one of the following criteria for high risk for SUID:
  • Infant race: Black or African American; and/or American Indian or Alaskan Native
  • Maternal education: 12 years or less
  • Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
  • Last menstrual cycle (LMP) or obstetrical estimate (OE) Gestational age at time of birth: \<37 weeks (preterm)
  • Maternal age at time of birth: \<25 years
  • Smoking status: Any self-reported maternal smoking during pregnancy

Exclusion criteria

  • Not primary caregiver
  • Does not speak English
  • Is not a US resident
  • Is not 18 years old or older
  • Infant did not use SNOO during the intended use period (i.e., birth to 6 months).
  • Infants does NOT meet at least one of the below risk criteria:
  • Infant race: Black or African American; and/or American Indian or Alaskan Native
  • Maternal education: 12 years or less
  • Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
  • LMP or OE Gestational age at time of birth: \<37 weeks (preterm)
  • Maternal age at time of birth: \<25 years
  • Smoking status: Any self-reported maternal smoking during pregnancy

Where

  • Los Angeles, California

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Sep 5, 2025 · Source of record for eligibility and locations

📊
1 of 1000 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Los Angeles

California

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Fanconi Anemia Trials by City

Browse all fanconi anemia clinical trials in these cities — not just this study.

Browse More Trials by Condition

Looking for Infant Death Treatment in Los Angeles?

Join others in California exploring innovative treatment options through clinical research

Infant Death Treatment Options in Los Angeles, California

If you're searching for Infant Death treatment in Los Angeles, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Los Angeles and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Infant Death. All study-related care is provided at no cost to participants.

Local Sites
1 locations in California
Now Enrolling
Up to 1000 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Infant Death?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Infant Death

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Infant Death Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06361303. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.